Winton Group’s Novavax NVAX Stock Holding History

Winton Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,784	Closed	-$379K	–	1439
2021 Q2	$379K	Sell	1,784 -381	-18%	-$69.8K	0.02%	1064
2021 Q1	$393K	Buy	+2,165	New	+$431K	0.02%	1009
2020 Q4	–	Sell	-8,252	Closed	-$894K	–	1457
2020 Q3	$894K	Buy	+8,252	New	+$1.01M	0.03%	865
2019 Q4	–	Sell	-76,399	Closed	-$384K	–	1707
2019 Q3	$384K	Buy	+76,399	New	+$418K	﹤0.01%	1179
2019 Q2	–	Sell	-1,362	Closed	-$15K	–	1242
2019 Q1	$15K	Buy	+1,362	New	+$43K	﹤0.01%	1062

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Winton Group's NVAX Position: Q3 2021 in Review

Winton Group sold out of Novavax (NVAX) in Q3 2021, closing a stake of 1,784 shares — an estimated $379K sold.

Winton Group first reported a position in NVAX in Q1 2019 and held it in 5 quarters. The position peaked at $894K in Q3 2020. 442 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

Winton Group reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
Winton Group sold 1,784 Novavax shares in Q3 2021, an estimated $379K.
Winton Group first reported a position in Novavax in Q1 2019 and held it in 5 quarters.
Winton Group's Novavax position peaked at $894K in Q3 2020.
442 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on Winton Group's 13F filing for Q3 2021, filed 28 Oct 2021.